Huashu Pharmaceutical Corporation
Overview
Huashu Pharmaceutical Corporation is a pharmaceutical company headquartered in Shijiazhuang, China, founded in 1987, with 501-1,000 employees.
Active pharmaceutical ingredients supplied
Substances Huashu Pharmaceutical Corporation is evidenced to supply (US FDA Drug Master File or EU CEP). Open any ingredient to see its full supplier landscape, CAS number and patent status.
API / Drug Master Files
Huashu Pharmaceutical Corporation holds 2 active (4 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.
- NEOMYCIN SULFATEActive2004-05-17
- OXYTETRACYCLINE BASEActive1995-09-08
- DOXYCYCLINE MONOHYDRATEInactive2005-04-26
- DOXYCYCLINE HYCLATEInactive2005-04-26
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Huashu Pharmaceutical Corporation in our records. PharmaTek screens the full directory against live FDA enforcement data.
Is this Huashu Pharmaceutical Corporation? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.